News and Trends 24 Jan 2023
CytoReason expands deal with Sanofi to look at IBD
CytoReason, which creates computational disease modeling, has announced an expansion of its collaboration with Sanofi. The multi-year collaboration will further…
CytoReason
- Latest Posts
News and Trends 20 Sep 2022
CytoReason and Pfizer agree deal worth up to $110M for AI drug discovery and development
In a deal with a potential value of $110 million over the next five years, CytoReason has announced an extension…
